all items  in current results   Refine your search within these categories: 1. Human Genes: all > Latent transforming growth factor, beta binding proteins [HGNC:LTBP] latent transforming growth factor beta binding protein 2 [HGNC:LTBP2] (14) latent transforming growth factor beta binding protein 3 [HGNC:LTBP3] (3) latent transforming growth factor beta binding protein 4 [HGNC:LTBP4] (8) 2. Interaction: Human Genes and Chemicals (group results) Affects (24) Decreases (24) Increases (24) 3. Bioactivity 4. Semantic Terms (group results) Entity [STY:T071] (3) A. Anatomy (group results) Body Regions [MESH:D001829] (20) Cardiovascular System [MESH:D002319] (19) Cells [MESH:D002477] (22) Digestive System [MESH:D004064] (16) Embryonic Structures [MESH:D004628] (4) Endocrine System [MESH:D004703] (7) Hemic and Immune Systems [MESH:D006424] (6) Integumentary System [MESH:D034582] (2) Musculoskeletal System [MESH:D009141] (21) Nervous System [MESH:D009420] (14) more... B. Organisms C01. Bacterial Infections and Mycoses (group results) Bacterial Infections [MESH:D001424] (24) Infection [MESH:D007239] (24) Mycoses [MESH:D009181] (10) C02. Virus Diseases (group results) Virus Diseases [MESH:D014777] (24) C03. Parasitic Diseases (group results) Parasitic Diseases [MESH:D010272] (24) C04. Neoplasms (group results) Neoplasms [MESH:D009369] (24) C05. Musculoskeletal Diseases (group results) Musculoskeletal Diseases [MESH:D009140] (24) C06. Digestive System Diseases (group results) Digestive System Diseases [MESH:D004066] (24) C07. Stomatognathic Diseases (group results) Stomatognathic Diseases [MESH:D009057] (24) C08. Respiratory Tract Diseases (group results) Respiratory Tract Diseases [MESH:D012140] (24) Z. Exceptions (18) C09. Otorhinolaryngologic Diseases (group results) Otorhinolaryngologic Diseases [MESH:D010038] (24) C10. Nervous System Diseases (group results) Nervous System Diseases [MESH:D009422] (24) Z. Exceptions (23) C11. Eye Diseases (group results) Eye Diseases [MESH:D005128] (24) Z. Exceptions (4) C12. Male Urogenital Diseases (group results) Male Urogenital Diseases [MESH:D052801] (24) C13. Female Urogenital Diseases and Pregnancy Complications (group results) Female Urogenital Diseases [MESH:D052776] (24) Pregnancy Complications [MESH:D011248] (24) Z. Exceptions (21) C14. Cardiovascular Diseases (group results) Cardiovascular Diseases [MESH:D002318] (24) Z. Exceptions (23) C15. Hemic and Lymphatic Diseases (group results) Hematologic Diseases [MESH:D006402] (24) Lymphatic Diseases [MESH:D008206] (24) Z. Exceptions (15) C16. Congenital, Hereditary, and Neonatal Diseases and Abnormalities (group results) Congenital, Hereditary, and Neonatal Diseases and Abnormalities [MESH:D009358] (24) C17. Skin and Connective Tissue Diseases (group results) Connective Tissue Diseases [MESH:D003240] (24) Skin Diseases [MESH:D012871] (24) C18. Nutritional and Metabolic Diseases (group results) Metabolic Diseases [MESH:D008659] (24) Nutrition Disorders [MESH:D009748] (24) Z. Exceptions (14) C19. Endocrine System Diseases (group results) Endocrine System Diseases [MESH:D004700] (24) Z. Exceptions (11) C20. Immune System Diseases (group results) Immune System Diseases [MESH:D007154] (24) Z. Exceptions (12) C21. Disorders of Environmental Origin C22. Animal Diseases (group results) Animal Diseases [MESH:D000820] (24) C23. Pathological Conditions, Signs and Symptoms (group results) Pathologic Processes [MESH:D010335] (24) Pathological Conditions, Anatomical [MESH:D020763] (24) Signs and Symptoms [MESH:D012816] (24) C24. Occupational Diseases (group results) Occupational Diseases [MESH:D009784] (23) Z. Exceptions (19) C25. Chemically-Induced Disorders (group results) Drug-Related Side Effects and Adverse Reactions [MESH:D064420] (24) Poisoning [MESH:D011041] (24) Substance-Related Disorders [MESH:D019966] (24) C26. Wounds and Injuries (group results) Wounds and Injuries [MESH:D014947] (24) Z. Exceptions (22) D01. Inorganic Chemicals (group results) Electrolytes [MESH:D004573] (1) Elements [MESH:D004602] (4) Free Radicals [MESH:D005609] (1) Metals [MESH:D008670] (3) Minerals [MESH:D008903] (1) Oxygen Compounds [MESH:D017601] (1) D02. Organic Chemicals (group results) Organic Chemicals [MESH:D009930] (12) D03. Heterocyclic Compounds (group results) Heterocyclic Compounds [MESH:D006571] (7) D04. Polycyclic Compounds (group results) Polycyclic Compounds [MESH:D011083] (4) D05. Macromolecular Substances D06. Hormones, Hormone Substitutes, and Hormone Antagonists (group results) Hormones [MESH:D006728] (1) D08. Enzymes and Coenzymes D09. Carbohydrates (group results) Carbohydrates [MESH:D002241] (1) D10. Lipids (group results) Lipids [MESH:D008055] (2) D12. Amino Acids, Peptides, and Proteins D13. Nucleic Acids, Nucleotides, and Nucleosides D20. Complex Mixtures D23. Biological Factors D25. Biomedical and Dental Materials D26. Pharmaceutical Preparations D27. Chemical Actions and Uses (group results) Pharmacologic Actions [MESH:D020228] (3) Specialty Uses of Chemicals [MESH:D020313] (2) E. Analytical, Diagnostic and Therapeutic Techniques and Equipment (group results) Diagnosis [MESH:D003933] (21) F. Psychiatry and Psychology (group results) Behavior and Behavior Mechanisms [MESH:D001520] (21) Mental Disorders [MESH:D001523] (22) Psychological Phenomena and Processes [MESH:D011579] (2) G. Phenomena and Processes (group results) Chemical Phenomena [MESH:D055598] (1) Circulatory and Respiratory Physiological Phenomena [MESH:D002943] (12) Genetic Phenomena [MESH:D055614] (23) Musculoskeletal and Neural Physiological Phenomena [MESH:D055687] (3) Physiological Phenomena [MESH:D010829] (12) Reproductive and Urinary Physiological Phenomena [MESH:D012101] (1) I. Anthropology, Education, Sociology and Social Phenomena J. Technology, Industry, Agriculture N. Health Care Recently Viewed Items Go to Item History

These terms define your current search. Click the × to remove a term. 1. Human Genes: Latent transforming growth factor, beta binding proteins [HGNC:LTBP] × 24 items, grouped by 1. Human Genes (view ungrouped items) latent transforming growth factor beta binding protein 2 [HGNC:LTBP2] (14)    MESH:C018021   cobaltous chloride C018021               MESH:C558013   NSC 689534 C558013               MESH:D001564   Benzo(a)pyrene D001564               MESH:D002117   Calcitriol D002117               MESH:D003300   Copper D003300               MESH:D004317   Doxorubicin D004317               MESH:D005576   Colforsin D005576               MESH:D013629   Tamoxifen D013629               MESH:D014747   Vinblastine D014747               MESH:D015032   Zinc D015032               MESH:D016685   Mitomycin D016685               MESH:D017239   Paclitaxel D017239               MESH:D019772   Topotecan D019772               MESH:D020122   tert-Butylhydroperoxide D020122               latent transforming growth factor beta binding protein 3 [HGNC:LTBP3] (3)    MESH:C004648   testosterone enanthate C004648               MESH:C044887   beta-methylcholine C044887               MESH:D012643   Selenium D012643               latent transforming growth factor beta binding protein 4 [HGNC:LTBP4] (8)    MESH:C020972   pyrrolidine dithiocarbamic acid C020972               MESH:C028559   bathocuproine sulfonate C028559               MESH:C057693   troglitazone C057693               MESH:D006861   Hydrogen Peroxide D006861               MESH:D012643   Selenium D012643               MESH:D013755   Tetradecanoylphorbol Acetate D013755               MESH:D014810   Vitamin E D014810               MESH:D015759   Ionomycin D015759